ArticlebioRxiv : the preprint server for biology2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer.
Joan Jacob et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.